We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Forward Seeks 2nd Fed. Circ. Look At MS Drug Patent Case

Law360 (November 26, 2018, 4:23 PM EST) -- Forward Pharma AS has urged the full Federal Circuit to review a panel decision that prevented it from securing royalties from Biogen MA on the multibillion-dollar multiple sclerosis drug Tecfidera, saying...
To view the full article, register now.

Documents

Related

Sections

Case Information

Case Title

Subscribers Only

Case Number

Subscribers Only

Court

Appellate - Federal Circuit

Nature of Suit

Date Filed

May 31, 2017

Law Firms

Companies

Patents

Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.